Agile Therapeutics is a women's healthcare company. The company's primary product candidate, Twirla, also known as AG200-15, is a once-weekly prescription combination hormonal contraceptive patch that is at the end of clinical development. Twirla is a combined hormonal contraceptives patch that contains the active ingredients ethinyl estradiol, which is a synthetic estrogen, and levonorgestrel, which is a type of progestin, a synthetic steroid hormone. The company also has a pipeline of other transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle, and AG200-SP, which is a regimen designed to provide shorter lighter periods.

Civeo is a provider of a suite of hospitality services for its guests, including lodging, food service, housekeeping and maintenance at accommodation facilities that it or its customers own. The company also provides services that support the day-to-day operations of accommodation facilities, such as laundry, facility management and maintenance, water and wastewater treatment, power generation, communication systems, security and group logistics. The company provides development activities for workforce accommodation facilities, including site selection, permitting, engineering and design, manufacturing management and site construction. The company operates in three business segments: Canada, Australia and U.S.

Extraction Oil & Gas is an independent oil and gas company focused on the acquisition, development, and production of oil, natural gas, and natural gas liquid (NGL) reserves, as well as the construction and support of midstream assets to gather and process crude oil and gas production in the Rocky Mountain region, primarily in the Wattenberg Field of the Denver-Julesburg Basin (the DJ Basin) of Colorado. The company is primarily focused on developing its proved reserves and production primarily through the development of its inventory of identified liquids-rich horizontal drilling locations in the DJ Basin.

HG Holdings has an interest in HC Government Realty Trust, Inc., which owns and operates a portfolio of single-tenant properties leased throughout the United States for occupancy by federal agencies including the Federal Bureau of Investigation, the Drug Enforcement Administration, the Social Security Administration and the Department of Transportation.

Spectrum Pharmaceuticals is a biopharma company. The company's product portfolio consists of in-development drug products for the treatment of cancer patients. The company has three drugs in development: ROLONTIS, which is a long-acting granulocyte colony-stimulating for chemotherapy-induced neutropenia; Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in development for treating relapsed or refractory non-Hodgkin's lymphoma patients (including diffuse large B-cell lymphoma).

Texas Pacific Land Trust is engaged in holding title to tracts of land in several counties in West Texas. The company has two segments: Land and Resource Management, which encompasses the business of managing the land and related resources in West Texas owned by the company; and Water Service and Operations, which encompasses the business of providing water offerings to operators in the Permian Basin. Texas Pacific Water Resources LLC, a single member LLC and wholly owned subsidiary of the company, provides water offerings. These services include, but are not limited to, water sourcing, produced-water gathering/treatment, infrastructure development, water tracking, analytics and well testing services.